Back to search

Article

Myeloperoxidase is a Critical Mediator of Anthracycline-induced Cardiomyopathy

2022-12-13

Abstract excerpt

<title>Abstract</title> <p>Cardiotoxicity is a major complication of anthracycline therapy that negatively impacts prognosis. Effective pharmacotherapies for prevention of anthracycline-induced cardiomyopathy (AICM) are currently lacking. Increased plasma levels of the neutrophil-derived enzyme myeloperoxidase (MPO) predict occurrence of AICM in humans. We hypothesized that MPO release causally contributes to AIC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d22eae65-09af-5c19-915f-aa15789ef1d2
DOI
10.21203/rs.3.rs-2219349/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Myeloperoxidase is a Critical Mediator of Anthracycline-induced CardiomyopathyDOI 10.21203/rs.3.rs-2219349/v1
Select a neighboring publication to make it the new centre.